Attention to associated diagnoses, such as infection and systemic lupus erythematosus
(SLE), is critical at the time of diagnosis. All patients should be treated with anticoagulants …

Antiphospholipid syndrome (APS) is classified as the association of thrombotic events
and/or obstetric morbidity in patients persistently positive for antiphospholipid antibodies …

BACKGROUND. Administration of conventional antithrombotic treatment (low-dose aspirin
plus low–molecular weight heparin [LDA+ LMWH]) for obstetric antiphospholipid syndrome …

Background: Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized
by thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …

Thrombotic manifestations of antiphospholipid syndrome (APS) are well known, and various
non-stroke neuro-psychiatric manifestations (NPMs) have also been consistently described …

Hidroxicloroquina en el tratamiento de las enfermedades autoinmunes sistémicas SciELO -
Scientific Electronic Library Online vol.144 número2 Escenario actual y perspectivas de la …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
presence of antiphospholipid antibodies (aPL) in subjects presenting with thrombosis and/or …

Objectives Although the data from primary antiphospholipid syndrome (APS) suggests a
beneficial effect of rituximab usage, its therapeutic role remains to be defined in systemic …

Aim: Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis and/or
gestational morbidity in patients with antiphospholipid autoantibodies (aPL). Over recent …